Contact Information: info@facts-care.org
Register

 

Cardiovascular-Thoracic (CVT) Critical Care 2014

Celebrating the 11-Year Conference Anniversary!

Presented in 3 days:

Thursday Oct. 9 thru Saturday Oct. 11, 2014

Omni Shoreham Hotel Washington, DC

This 11th annual multi-disciplinary CME conference is dedicated to further advancing knowledge and expertise in the complex field of Cardiovascular-Thoracic (CVT) Critical Care. It is designed to bring together the entire team of health care professionals that provide care for patients undergoing CVT operations and procedures, including now endovascular procedures.

Latest Concepts, Protocols, & Technology to Increase Speed of Recovery, Safety & Patient Comfort

 

 

 

 

   

Omni Shoreham Hotel:

Omni Shoreham Hotel

(202) 234-0700

2500 Calvert Street NW

Washington, DC 20008

 

Register

 

  aats
   


Facts Care Facebook Page


Important Information

Description »


This 11th annual multi-disciplinary CME conference is dedicated to further advancing knowledge and expertise in the complex field of Cardiovascular-Thoracic (CVT) Critical Care. It is designed to bring together the entire team of health care professionals that provide care for patients undergoing CVT operations and interventional procedures.

The conference is directed to:

  • Surgeons, Cardiologists, Interventionalists
  • Intensivists & Anesthesiologists
  • Hospitalists
  • Critical Care Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Perfusionists
  • Cath Lab Professionals
  • Pharmacists
  • Respiratory Therapists
  • Nutritionists

 
The conference addresses the unique physiology, operations, procedures, and potential complications of CVT patients. Latest management strategies for challenging clinical problems will be presented and current controversies discussed. Experts and world authorities will focus on the latest concepts, technology, management protocols, and clinical experience in their specialties.

The program includes faculty presentations, abstract-based scientific sessions, symposia regarding major issues, audience-panel discussions and workshops. Approaches and specific protocols will be related to clinical data, so that participants can structure their clinical practice on evidence-based medicine.

With the field of CVT critical care continuing to change rapidly, it is anticipated that participation in the conference will lead to implementation of new concepts, protocols, and technology. The overall goal is to make the recovery of patients from CVT surgery and interventional procedures faster, safer, and more comfortable.

Fee Structure »


Take advantage of Early Bird pricing and register by October 1, 2014. FACTS-Care Members receive a 15% discount of all prices below. Become a Member today!

Members of these organizations also receive a 15% discount on both the early and full conference registration fees: AATS, STS, SCA (Soc of CV Anes).


Physicians

Allied Health Professionals

Fellows / Students

Full Conference (Early Bird- register by 10/1)

$655

$455

$345

Full Conference (After 10/1)

$755

$555

$445

Thursday and Friday only

$700

$500

$350

Thursday and Saturday only

$650

$450

$350

Friday and Saturday only

$650

$450

$350

Thursday only

$550

$375

$300

Friday only

$550

$375

$300

Saturday only

$400

$300

$225

Note: All registration cancellations are subject to cancellation fee

Contact Us »


For additional information please contact:

Nevin Katz, MD

President & Executive Director, FACTS-Care

Email: info@facts-care.org

 

Mowahib Vermillion

Administrative Assistant, FACTS-Care

Email: mvermillion@facts-care.org or

info@facts-care.org

FACTS-Care

1912 Foxhall Road

McLean, VA 22101

703-992-9948

Practice Gaps and Needs Assessment »


Practice Gaps and Needs Analysis (from 2013)

Practice Gaps

In the last few years, there have been important new developments in the specialty of CVT critical care which have the potential to enhance the quality and safety of CVT critical care. Practice gaps are identified in recent articles such as the one focused on The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models. Overall the actual cardiac surgical outcomes are clearly below ideal performance, with the recent analyses documenting importance incidences of : mortality, stroke, reoperation, renal failure, deep sternal wound infection, prolonged ventilation, composite major morbidity, and prolonged length of stay.

At the 2011 Annual Meeting of The Society of Thoracic Surgeons, Shannon and colleagues from the University of Michigan presented important new data in regard to reducing complications and mortality in cardiac surgical patients. Their presentation was entitled "A Novel Method to Evaluate Mortality in Cardiac Surgery: Phase of Care Mortality Analysis, POCMA - A Statewide Quality Collaborative Initiative." They reported that 41% of the mortality during the ICU phase of care is "potentially avoidable." This study, which was subsequently published in the Annals of Thoracic Surgery, emphasizes that important practice gaps still exist.

This conference addresses the major need to highlight the new knowledge in CVT Critical Care so that the developments can be integrated into the practices of the specialty to narrow the practice gaps.

References:
Shahian DM and Edwards FH. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Introduction. Ann Thor Surg 2009;88:S1 and related articles Ann Thorac Surg 2009;88:S2-62.

Shannon FL, Fazzalari FL, Theurer PF, Bell, GF, Sutcliffe KM, Prager RL. A method to evaluate cardiac surgery mortality: Phase of care mortality analysis. Ann Thorac Surg 2012;93:36-43.

Nast PA, Avidan M, Harris CB, Krauss MJ, Jacobsohn E, Petlin A, Dunagan WC, Fraser VJ. Reporting and classification of patient safety events in a cardiothoracic intensive care unit and cardiothoracic postoperative care unit. J Thorac Cardiovasc Surg2005;130:1137-43.

Toumpoulis IK, Anagnostopoulos CE, Swistel DG, DeRose J. Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery? Eur J Cardiothoracic Surg 2005;27:128-133.

 

Needs Assessment

Cardiovascular-thoracic (CVT) critical care is now recognized as a unique specialty within the frameworks of CVT surgery, interventional cardiology, interventional radiology and general critical care. The overall field of CVT critical care now includes care of patients undergoing not only classical cardiac surgical operations, but also endovascular and minimally invasive surgery, interventional cardiology procedures, and interventional radiological procedures.

Although the CVT surgeon has traditionally provided perioperative care with the assistance of residents and fellows, the organization of the CVT critical care team is changing. CVT critical care is increasingly being provided by a multi-disciplinary team. The team includes: CVT surgeons, intensivists and anesthesiologists, hospitalists, critical care nurses and nurse practitioners, physician assistants, perfusionists, cath lab professionals, respiratory therapists, pharmacists, and nutritionists. It is essential that these multi-disciplinary professionals share a broad understanding of the care, so that they can function well as a team to enhance speed of recovery, quality, safety, and patient comfort.

The increasing complexity of CVT critical care requires a new level of critical care performance. This new critical care specialty is faced with major challenges:
 

  • A rapid evolution in critical care concepts, pharmacology and technology.
  • The unique physiologic states and complications experienced by CVT patients.
  • The aging CVT patient population with more advanced primary disease and associated conditions.
  • Major advances in surgical techniques, interventional procedures and the accompanying technology.
  • National regulations limiting house staff work hours that accentuate the shortage of critical care staff.
  • The difficulty in providing comfortable care with patients subjected to multiple negative sensory inputs including monitoring sounds, alarms, technical language, and procedures.
  • The increasing number of disciplines included on the CVT critical care team.
  • The well-documented compromises in medical practice safety.

 

This 10th annual multi-disciplinary conference, “Cardiovascular-Thoracic (CVT) Critical Care 2013,” addresses these challenges as follows:

  • The conference is dedicated to presenting the latest information and innovative concepts and technology in CVT Critical Care.
  • Basic approaches and specific protocols will be related to clinical data so that participants can structure their clinical practice on “evidence based medicine.”
  • The program agenda has been designed with the assistance of multi-disciplinary specialists.
  • Experts and world authorities will present the latest concepts, protocols and clinical experience in their specialties.
  • The importance of the multi-disciplinary approach to CVT critical care will be emphasized.
  • To help critical care personnel understand the patient’s perspective, a discussion led by the patient organization Mended Hearts will be presented.

 

In the last few years, there have been important new developments in the specialty which have the potential to enhance the quality and safety of CVT critical care. This conference addresses the major need to highlight new developments, so that the latest knowledge can be integrated into practice:

  • New hemodynamic monitoring and point of care technologies have been developed. How to employ these new methods to guide management will be discussed.
  • There is an evolution in cardiovascular therapeutic agents and interventions to address the challenges of low cardiac output, right heart failure, and pulmonary hypertension. New pharmacologic and interventional approaches for impaired hemodynamics will be presented and further discussed in the audience panel discussions.
  • Bedside ultrasound technology now makes possible early bedside diagnosis of mechanical hemodynamic problems and increases the safety of deep line placement. The bedside ultrasound workshop will facilitate integration of these techniques into clinical practice.
  • The technology to provide circulatory support continues to evolve rapidly and includes a variety of percutaneous devices. The postoperative management of patients on such devices is complex and will be addressed through a presentation and a workshop.
  • Extra-corporeal membrane oxygenation (ECMO) has increasingly been employed for the treatment of acute respiratory failure. New information regarding the application of ECMO will be the subject of a presentation and will be addressed in a workshop.
  • Adequate, safe pain control and sedation in CVT patients and the prevention and treatment of delirium are continuing challenges in the CVT ICU. Latest data and management protocols will be presented.
  • Management of patients who are bleeding after cardiac surgery continues to challenge the CVT ICU team and will be discussed.
  • Volume overload and acute renal failure continue to be major challenges in CVT patients. Protocols and controversies regarding renal replacement therapy will be presented.
  • Infection continues to be an important complication in CVT patients. The latest concepts and guidelines to prevent and manage sepsis will be discussed.

 

Educational Objectives »

The overall educational objectives of “Cardiovascular-Thoracic (CVT) Critical Care 2014” are:

  • Apply the latest concepts, technology and developments in CVT critical care to optimize patient outcomes.
  • Understand the latest innovations and protocols in cardiac, respiratory and renal support. 
  • Recognize the importance of the multi-disciplinary team approach in CVT critical care and principles of the team coordination.

  Educational objectives of “Cardiovascular-Thoracic (CVT) Critical Care 2014” include:

  • Evaluate the latest choices in hemodynamic monitoring and point of care technology.
  • Apply the pharmacologic and mechanical support approaches to severe postoperative heart failure.
  • Examine how interventional cardiology procedures are employed before and after cardiac surgery.
  • Integrate into practice the latest concepts and protocols for diuretics and renal replacement therapy.
  • Evaluate how current ventricular assist devices are employed in CVT critical care and how to deal with emergencies.
  • Examine a stepwise approach to bleeding after cardiac surgery.
  • Understand how optimal sedation and analgesia are achieved for complex CVT critical care patients.
  • Evaluate how ECMO technology and protocols are employed in CVT critical care.
  • Understand how the latest bedside echocardiography - ultrasound technology is used to diagnosis hemodynamic mechanical problems and to guide placement of deep catheters.
  • Examine how the latest hemodynamic monitoring technology is used to guide management of low cardiac output.
  • Obtain a perspective of how CVT ICU protocols are developed and implemented and how the results are analyzed.
  • Apply the latest diagnostic and management protocols to the occurrence of pulmonary embolism in CVT patients.
  • Evaluate the latest concepts and protocols for prevention, diagnosis and management of acute stroke after cardiac surgery.
  • Assess the latest pharmacologic and surgical approaches to atrial fibrillation.
  • Apply the latest protocols in anticoagulation after cardiac valve replacement surgery.
  • Evaluate the latest methods of nutritional support for CVT ICU patients.
  • Gain an understanding of the latest innovations in cardiac surgery.
  • Assess the latest advances in minimally invasive thoracic surgery and the associated postoperative care.
  • Understand the selection of open versus percutaneous tracheostomy and the timing of the procedure.
  • Apply the latest preventive and management protocols to GI bleeding in CVT patients.
  • Evaluate the perioperative management of acute and chronic hepatic failure in CVT patients.
  • Assess the ethical issues associated with advanced critical care technology.
  • Integrate into practice the latest principles and protocols for the management of pneumonia in CVT ICU patients.
  • Understand the patient’s and family’s perspective regarding CVT critical care.

 

CE Accreditation »


This activity will be planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Nurses

This activity is pending approval with The Association of periOperative Registered Nurses.

 

Perfusionist Accreditation

This activity is pending approval with the American Board of Cardiovascular Perfusion (ABCP).

Disclosure policy:

 

IFor further information on the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, please visit www.accme.org.

Group Rate Hotel Information »


Omni Shoreham Hotel Washington, DC
The Omni Shoreham Hotel welcomes attendees of Cardiovascular-Thoracic Critical Care 2014. To reserve your room now and receive the special conference rate simply click on the "book now" button below.

Conference Dates: Oct 9, 2014 - Oct 11, 2014
Additional Dates: Oct 8, 2013 - Oct 14, 2014
Special Rate: $259 per night Book Now »
Book By: September 10, 2014


Omni Shoreham Hotel

(202) 234-0700

2500 Calvert St NW, Washington, DC 20008

Group Code 12400611715


Agenda, Faculty & Abstract/Poster Submission

Agenda »

From 2013

Thursday, October 10, 2013

7:00 am – 8:00 am
Light Breakfast & Registration

Session I  –  Introduction & Cardiovascular

8:00 am – 8:05am
Welcome &  Introduction to the Program
Nevin M. Katz, MD

8:05 am – 8:20 am
Welcome & Perspective from the FACTS-Care Board of Directors
John V. Conte, MD & Mary J. Zellinger, CCRN

8:20 am – 8:40 am
The 10-Year History of FACTS-Care
Nevin M. Katz, MD

8:40 am – 9:10 am
Management of Severe CHF with Pharmacologic & Device Support
Cardiologist TBA

9:10 am – 9:40 am
Permanent Ventricular Assist Device Readmissions & Emergencies – Case Scenarios
John V. Conte, MD, Jonathan W. Haft, MD, & Perfusionist TBA

9:40 am – 10:00 am
Audience Panel Discussion
Moderator: John V. Conte, MD
Panelists: Michael Doll, PA-C, Myra F. Ellis, CCRN,Jonathan W. Haft, MD,
Marsha Holton, CCRN, RCIS, FSICP, & Perfusionist TBA

10:00 am – 10:30 am
Refreshment Break - Exhibit Hall

Session II – Cardiac Transplantation

10:30 am – 11:00 am
Cardiac Transplantation – Postoperative Care & Immunosuppression
Jonathan W. Haft, MD

Session III – Innovative Approaches to CVT Critical Care - Abstract-Based Scientific Session

11:00 am – 11:45am
Moderators: Daniel L. Miller, MD & TBA
Presentation 1
TBA
Presentation 2
TBA


11:45 am – 12:00 pm
Intermission - Exhibit Hall

Professional Networking Luncheon Symposium  

12:00 pm – 1:15 pm
The Multi-Disciplinary CVT Support Team – Organization & Case Scenario

Moderators: Charles M. Geller, MD, Robert E. Molyneaux, PA-C &  Mary J. Zellinger, CCRN
Panelists: Pharmacist - Robert Warhurst, PharmD, Respiratory Therapist, Physical Therapist, Speech Language Pathologist, Nutritionist, Supportive -Palliative Care Specialist.

1:15 pm – 2:00  pm
Non-CME Focus Groups & Exhibit Hall Demonstrations - Latest Technology & Pharmaceuticals

Session IV – Thoracic Surgery & Respiratory Support

2:00 pm – 2:30 pm
Mechanical Ventilation & Weaning after Complex CVT Surgery – Case Scenarios
James P. Lamberti, MD

2:30 pm – 3:00 pm
Adult ECMO – Case Scenarios with Latest Strategies
William R. Lynch, MD & Hirose Hitoshi, MD

3:00 pm – 3:30 pm
Tracheal Surgery & Postop Care
Daniel L. Miller, MD

3:30 pm  – 4:00 pm
Cardiac Surgery Advanced Life Support (CALS) – Protocols & Results
Joel Dunning, PhD

4:00 pm – 4:30 pm
Refreshment Break - Exhibit Hall

 

Session V – Multi-Disciplinary Break Out Workshops

4:30 pm – 6:00 pm

Bronchoscopy Simulation
Director: James P. Lamberti, MD & Co-Director: Namrata Patil, MD
Cardiac Advanced Life Support (CALS) Protocols
Director: Joel Dunning, PhD; Co-Director: S. Jill Ley, RN, CNS,
Temporary Circulatory Support / ECMO - Protocols & Bedside Issues
Co-Directors: Jonathan W. Haft, MD, William R. Lynch, MD, & Perfusionist TBA

 

Friday, October 11, 2013

7:00 am – 8:00 am
Light Breakfast & Registration

Session VI – Endocrine Issues

Moderator: Joseph F. Dasta, MSc

8:00 am – 8:30 am
Adrenal & Thyroid Insufficiencies in the CVT ICU Patient
Jacqueline Jonklaas, MD, PhD

8:30 am – 9:00 am
Hyponatremia & Hypernatremia – Management in the CVT ICU
Joseph G. Verbalis, MD

Session VII – Ethical Issues

Moderator: Namrata Patil, MD

9:00 am – 9:30 am
The Ethics of Advanced Critical Care Technology
Melissa M. Goldstein, JD

Session VII – Andrew Foster Young Investigator Award

9:30 am – 10:00 am
Andrew Foster “Young Investigator” Presentation
Award Recipient & Joseph M. Giordano, MD

10:00 am – 10:30 am
Refreshment Break - Exhibit Hall

Session VIII – The Patient’s Perspective

10:30 am – 11:00 am
The Patient’s Perspective Panel
Mended Hearts Moderator & Representatives & Barbara Jacobs, CCRN

Session IX – Innovative  Approaches to CVT Critical Care - Abstract-Based Scientific Session

11:00 am – 11:45am
Moderators: Danielle Blais, PharmD, & TBA
Presentation 1
TBA
Presentation 2
TBA

11:45am – 12:00 pm
Intermission - Exhibit Hall

Luncheon Symposium

12:15 pm – 1:15 pm
KEYNOTE ADDRESS: TBA
TBA

1:15 pm – 2:00 pm
Non-CME Focus Groups & Exhibit Hall Demonstrations - Latest Technology & Pharmaceuticals

Session X – Re-operative Cardiovascular Surgery

2:00 pm – 2:30 pm
The Challenges of Re-operative Cardiac Surgery
Duke E. Cameron, MD

Session XI – Innovations in Anticoagulation & Coagulopathy Management

Moderator: Nevin M. Katz, MD

2:30 pm – 3:00 pm
Latest Updates in the Use of Novel Oral Anticoagulant and Anti-platelet agents
Jessica Crow, PharmD

3:00 pm – 3:30 pm
Reversal of Anticoagulation
Jerrold H. Levy, MD

3:30 pm – 4:00 pm
Refreshment Break - Exhibit Hall

Session XII – Multi-Disciplinary Break Out Workshops

4:00 pm – 5:00 pm

Bedside Echocardiography & Ultrasound Guided Procedures
Director: Haney Mallemat, MD & Co-Director: Glenn Whitman, MD
Hemodynamic Simulation – Case Scenarios including Patient with VAD
Director: Nevin M. Katz, MD   
Temporary Pacing & Permanent Pacemakers in the ICU
Co-Directors: Myra F. Ellis, CCRN & TBA

Session XIII - Abstract-Based Poster Session

5:00 pm – 6:00 pm
Poster Session – Wine & Cheese Event - Exhibit Hall & Patio           

 

Saturday, October 12, 2013

7:00 am – 8:00 am
Light Breakfast and Registration

Session XIV – Sepsis

8:00 am – 8:30 am
Extended Antibiotic Infusion Therapy
Robert Warhurst, PharmD

8:30 am – 9:00  am
Surviving Sepsis Guidelines – Latest Challenges & Protocols
Philip S. Barie, MD

 

Session XV – Renal & Neurologic Issues & Best Practices

9:00 am – 9:30 am
Management of the CVT ICU Patient with Acute Renal Dysfunction &  Failure
TBA

9:30 am – 10:00 am
Acute Pain Management in the CVT ICU
Joseph F. Dasta, MSc

10:00 am – 10:30 am
General Surgical Complications after CVT Procedures – Diagnosis & Management
Philip S. Barie, MD

10:30 am – 11:15 am
Best Practices & Controversies
Audience - Multi-Disciplinary Panel Discussion
Moderator: Nevin M. Katz, MD
Panelists: Philip S. Barie, MD, Joseph F. Dasta, MSc,  Barbara Jacobs, CCRN, Michael Doll, PA-C, Donnie Goodwin, ACNP, Denese Sabatino, CCRN,  & Steven Simms, RN, BSN

11:15 am
Closing Comments
Nevin M. Katz, MD

 

Please Note: Agenda and Faculty are subject to change.

Faculty »


From 2013

Conference Director

Nevin M. Katz, MD
President & Executive Director, FACTS-Care
Associate Professor of Surgery
Johns Hopkins University
The Johns Hopkins Hospital
Baltimore, MD

 

Conference Co-Directors

Joseph F. Dasta, MSc
Professor Emeritus
The Ohio State University College of Pharmacy
Columbus, OH
Adjunct Professor
University of Texas College of Pharmacy
Round Rock, TX

Jerrold H. Levy, MD, FAHA, FCCM
Professor of Anesthesiology
Co-Director, Cardiothoracic ICU
Duke University Medical Center
Durham, North Carolina

Daniel L. Miller, MD
Chief, General Thoracic Surgery
Professor of Thoracic Surgery
Emory University
Atlanta, GA

Mary J. Zellinger, RN, MN, ANP-BC, CCRN-CSC
Clinical Nurse Specialist
Cardiovascular and Critical Care Services
Emory University Hospital
Atlanta, GA

 

 

Invited Faculty

Philip S. Barie, MD
Chief of Critical Care & Trauma
Professor of Surgery
Weill Cornell Medical Center
New York, NY

Danielle Blais, PharmD, BCPS
Cardiology Specialty Pharmacist
Clinical Assistant Professor
The Ohio State University Medical Center
Columbus, OH

Duke E. Cameron, MD
Cardiac Surgeon-In-Charge
The Johns Hopkins Hospital
Professor of Surgery
Johns Hopkins University
Baltimore, MD

John V. Conte, MD
Director, Mechanical Circulatory Support
The Johns Hopkins Hospital
Professor of Surgery
Johns Hopkins University
Baltimore, MD

Jessica R. Crow, PharmD
Clinical Specialist
Cardiac Surgical Intensive Care & Nutrition Support Service
The Johns Hopkins Hospital Department of Pharmacy
Baltimore, MD

Michael C. Doll, MPAS, PA-C
Chief Physician Assistant
Division of Cardiac Surgery
Geisinger Medical Center
Danville, PA

Joel Dunning, PhD
Consultant Cardiothoracic Surgeon
James Cook University Hospital
Middlesbrough, UK

Myra F. Ellis, RN, MSN, CCRN-CSC
Clinical Nurse IV – CT ICU
Duke University Hospital
Durham, NC

Charles M. Geller, MD
Division of Cardiac Surgery
Beth Israel Medical Center
New York, NY

Joseph M. Giordano, MD
Professor Emeritus
Department of Surgery
The George Washington University
Washington, DC

Melissa M. Goldstein, JD
Associate Professor
Department of Health Policy
School of Public Health & Health Sciences
The George Washington University
Washington, DC

Donnie Goodwin, ACNP
Cardiac Surgery Nurse Practitioner Coordinator
West Virginia University Heat Institute
Morgantown, WV

Jonathan W. Haft, MD
Director, Extra-Corporeal Life Support Program
Associate Director Cardiovascular Intensive Care Units
Associate Professor of Surgery & Anesthesia
University of Michigan
Ann Arbor, MI

Hitoshi Hirose, MD
Associate Professor of Surgery
Division of Cardiothoracic Surgery
Thomas Jefferson University
Philadelphia, PA

Marsha Holton, CCRN, RCIS, FSICP
President, Cardiovascular Orientation Programs
Clinical Coordinator
Indian Head, MD

Barbara S. Jacobs, RN, MSN, CCRN, CENP
Senior Director, Nursing Operations
Suburban Hospital
Johns Hopkins Medicine
Bethesda, MD  

Jacqueline Jonklaas, MD, PhD
Associate Professor of Medicine
Division of Endocrinology
Georgetown University
Washington, DC

James P. Lamberti, MD
Medical Director
Respiratory Care Services
INOVA Fairfax Hospital
Falls Church, VA

S. Jill Ley, RN, MS, CNS
Clinical Nurse Specialist
Adult & Pediatric Cardiac Surgery
California Pacific Medical Center
San Francisco, CA

William R. Lynch, MD
Associate Professor of Surgery
Section of Thoracic Surgery
University of Michigan
Ann Arbor, MI

Haney Mallemat, MD
Assistant Professor
Department of Critical Care Medicine
Department of Emergency Medicine
University of Maryland Medical Center
Baltimore, MD

Robert E. Molyneaux, PA-C
Chief Physician Assistant
Surgical Critical Care Services
Washington Hospital Center
Washington, DC

Namrata Patil, MD, MPH
Director, Thoracic Intermediate Care Unit
Associate Surgeon
Brigham & Women’s Hospital
Instructor in Surgery
Harvard Medical School
Boston, MA

Denese Sabatino, MSN, ARNP, NP-C, CCRN
Clinical Nurse Specialist
Department of Critical Care
Cleveland Clinic Florida
Weston, FL

Steven Simms, RN, BSN
Cath Lab Patient Care Director
Virginia Hospital Center
Arlington, VA

Joseph G. Verbalis, MD
Chief Division of Endocrinology & Metabolism
Professor of Medicine & Physiology
Georgetown University
Washington, DC

Robert Warhurst, PharmD
CV Critical Care Pharmacist
Clarian Health – Methodist Hospital
Indianapolis, IN

Glenn Whitman, MD
Director, Cardiac SICU
The Johns Hopkins Hospital
Associate Professor of Surgery
Johns Hopkins University
Baltimore, MD

 

Abstract Submission for Scientific Presentation »


Abstract-Based Scientific & Poster Sessions, and Andrew Foster Young Investigator Award

Due to high interest, FACTS-Care is extending the Abstract Submission Deadline to June 30, 2014!


FACTS-Care is very pleased to announce   “Abstract-Based Scientific Sessions” at “Cardiovascular-Thoracic (CVT) Critical Care 2014.” This is an important first for our annual multi-disciplinary CME conferences and is an excellent way to celebrate the 11-Year Anniversary of the conferences.

It has been clear from the beginning of our “CVT Critical Care” conferences, that many of our participants are dynamic leaders in their hospitals, and are involved with developing and studying innovations in CVT critical care.  These new sessions provide an opportunity for multi-disciplinary professionals to highlight their studies in the following categories:
- Management of CVT Critical Care Issues
- Evaluation of New Technology and Pharmaceuticals
- Organization of the CVT Critical Care Multi-Disciplinary Team

With this announcement we are opening our web site to submission of the abstracts by multi-disciplinary professionals from centers in the USA and around the world. The deadline for submission is June 30, 2014.

The Abstracts will be judged by the “Abstract Judging” subcommittee of our 2014 Program Committee. The “Abstract-Based Scientific Sessions” will be held on the 1st and 2nd days of the conference, Thurs Oct 9 and Fri Oct 10, from 11:00 am – 11:45 am.

Each session will consist of 2 presentations selected by the “Abstract Judging Committee.” The presentations will be 10 minutes, with a 5 minute Audience-Panel discussion to follow. Overall then, 4 presentations will selected, and the authors honored at the luncheons that follow.

If the authors so indicate, Submissions will be considered for presentation at the “Poster Session”in the Exhibit Hall, as well as for the “Abstract-Based Scientific Session.” Authors may submit Abstracts for presentation only at the Poster Session.The Posters will be displayed both days of the conference in the Exhibit Hall, and will be honored at a “Wine & Cheese Event” in the Exhibit Hall, Fri Oct 10, from 5:00 pm – 6:00 pm.

Please note that Abstracts submitted for the “Andrew Foster Young Investigator Award” can be considered for both the “Abstract-Based Scientific Session” and the “Poster Session.” Please see the information for this award below. Investigators for this Award must be 35 years of age or younger.


 

Abstract Submission Instructions:

Abstract Submissions for the “Abstract-Based Scientific Sessions” and the “Poster Session” are encouraged from all disciplines. Those abstracts submitted for the “Andrew Foster Young Investigator Award” must be from investigators 35 years of age or younger (Please see Award information).

Abstracts should be e-mailed to: info@facts-care.org, and adhere to the following guidelines:

Abstracts must include the following:
- Name and degrees(s) of all authors, with presenting author’s name in upper case.
- Name of the hospital(s) where the study was performed.
- Brief title of the abstract, including the nature of the study only.
- Do not underline the title.
- Abstract submitted for (1 or more): Abstract-Based Scientific Session, Poster Session, Andrew Foster Young Investigator

The abstract text should include the following:
- A concise statement of the investigation’s purpose.
- A brief explanation of the study’s materials and methods.
- A summary of the study’s results.
- Conclusions supported by the investigaton’s results.
 
Please note:
- Do not include references or graphics.
- Abstracts should not exceed 500 words.
- The Abstract deadline is June 30, 2014.

Due to high interest, FACTS-Care is extending the Abstract Submission Deadline to June 30, 2014!

 

The "Andrew Foster Young Investigator" Award


This award honors the memory of Andrew H. Foster, MD, former chief of the Division of Cardiothoracic Surgery and Associate Professor of Surgery at The George Washington University Medical Center. Dr. Foster lost his battle with lymphoma in July, 1999.

The Andrew H. Foster, MD Young Investigator Award will be given to a young investigator (aged less than 35 years) whose abstract describing research related to Cardiovascular-Thoracic Critical Care is selected best by the Research Conference Committee. Abstracts will be judged using a blinded format.

Include the following contact information and if you would like to be considered for the Andrew Foster Award (you must meet the criteria as indicated below on this page) for the presenting author on a cover page.

The Program Committee members will review your abstract, and you will be notified of their decision by Sept 5, 2014.

If your abstract is selected, you will be asked to present it as either (a) a poster only or (b) a 10 minute conference presentation on date TBD, as the winner of the Andrew Foster Award . You will receive complete information (including poster dimensions, set-up times, etc.) after notification of the Program Committee's decision.

If accepted for presentation or display, your abstract will be printed in the course syllabus as submitted, so please edit and proofread carefully.

If you have any questions about the above guidelines, please contact:

 

Nevin Katz, MD
President & Executive Director, FACTS-Care
Email: info@facts-care.org

or

 

Mowahib Vermillion

Administrative Assistant, FACTS-Care

Email: info@facts-care.org

 

 

Program Committee »

Program Committee

 

 

Danielle Blais, PharmD
Columbus, Ohio, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience.

Joseph Dasta
Round Rock, TX, USA
Faculty member is a consultant for Acel-Rx Pharmaceuticals, Cadence Pharmaceuticals, Covidien-Mallinckrodt, Edge Therapeutics, Hospira, Pacira Pharmaceuticals, Merck, and Otsuka American Pharmaceuticals. Faculty member is on Speakers Bureau for Cadence Pharmaceuticals and Pacira Phrmaceuticals. Faculty member plans on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience

Charles Geller, MD
New York, New York, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Jonathan W. Haft, MD
Ann Arbor, Michigan, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience. 

Hitoshi Hirose, MD
Philadelphia, PA, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Marsha Holton, CCRN
Bethesda, Maryland, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Nevin M. Katz, MD
McLean, VA, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Jerrold Levy, MD
Durham, North Carolina, USA
Faculty member is a consultant for Boehringer Ingelheim and CSL Behring. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience. 

William R. Lynch, MD
Ann Arbor, MI, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member plans on discussing unlabeled/investigational uses of a commercial product.

Robert E. Molyneaux, PA-C
Washington, DC USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Namrata Patil, MD
Boston, Massachusetts, USA
Faculty member is a Minor Stockholder for GE, Canyon Pharmaceuticals, and Intel Corp.  Faculty member receives Grant/Research Support from Canyon Pharmaceuticals and NIAID. 
Faculty member plans on discussing unlabeled/investigational uses of commercial products and will disclose this to the audience.

Denese Sabatino, CCRN
Miami, Florida USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Robert D.  Warhurst, PharmD
Indianapolis, Indiana, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Mary J. Zellinger, CCRN
Atlanta, Georgia, USA
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

 

 

 


Supporters and Exhibitors

Council for Excellence »

Council for Excellence

 

We are grateful for the support of the following members of FACTS-Care’s Council for Excellence in CVT Critical Care:

 

   
Edwards Lifesciences edwards
Abbott Point of Care abbott

SonoSite, Inc

sonosite
The Medicines Company abbott
The Mended Heart mh
Abiomed abiomed
Hospira hospira
Grifols a
Gambro s
Masimo a
   

 

2013 Exhibitors »

 

 

Gold Exhibitors:

Edwards Lifesciences edwards
Abiomed abiomed
   
   
   

 

Silver Exhibitors:

Elsevier  
Hospira hospira
Grifols a
Haemonetics  
   
   

 

Bronze Exhibitors:

Abbott Point of Care  
Cornerstone Therapeutics  
NxStage Medical  
rEVO Biologics  
   

 

miller
conf
Download 2013 Brochure

Home | Annual Conference | Regional Conference | On-Line CE | About | Contact
Privacy Policy | Membership | Testimonials

© FACTS-Care - All Rights Reserved